JENNIFER CLYSDALE: Open Payments
NPI 1386405678 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,024 in 96 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $975 · 2025 $2,024
Food & beverage: $2,024
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $481 |
| Teva Pharmaceuticals USA, Inc. | 17 | $386 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $314 |
| E.R. Squibb & Sons, L.L.C. | 5 | $165 |
| Neurocrine BioSciences, Inc. | 9 | $154 |
| Otsuka America Pharmaceutical, Inc. | 11 | $139 |
| Alkermes, Inc. | 1 | $121 |
| JAZZ PHARMACEUTICALS INC. | 4 | $105 |
| Lundbeck LLC | 3 | $60 |
| Braeburn Inc. | 2 | $47 |
Products named: VRAYLAR, UZEDY, CAPLYTA, REXULTI, COBENFY, INGREZZA, ARISTADA, XYWAV.
Industry payments across NM — which companies pay providers there.
